Covid and inflation dominated corporate fears in recent years, but now companies say government regulation has returned as the biggest threat to business.
Covid and inflation dominated corporate fears in recent years, but now companies say government regulation has returned as the biggest threat to business.
Covid and inflation dominated corporate fears in recent years, but now companies say government regulation has returned as the biggest threat to business.
Covid and inflation dominated corporate fears in recent years, but now companies say government regulation has returned as the biggest threat to business.
The ideas lined out in the workshop summary mimic some of the FTC’s recent positions regarding concentration in the pharmaceutical industry, including its efforts to gain insight into PBMs through the ongoing 6(b) study and its recent suit to block the Amgen-Horizon Therapeutics acquisition.